SCHEMBL3697787

SCHEMBL3697787

CC(C)[C@H]1c2ccc(F)cc2C(F)(F)C[C@@]1(O)CC(=O)N(C)CCCc1nc2ccccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.61
CACNA1H O95180 12/20 0.57
CACNA1C Q13936 10/20 0.57
CYP2D6 P10635 4/20 0.53
MAPT P10636 4/20 0.52
CACNA1B Q00975 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.52
KCNH2 Q12809 2/20 0.52
ABCB11 O95342 2/20 0.52
NPC1 O15118 2/20 0.52
TP53 P04637 2/20 0.52
CYP1A2 P05177 2/20 0.52
ALOX15 P16050 2/20 0.52
MAPK1 P28482 2/20 0.52
CYP2C19 P33261 2/20 0.52
THPO P40225 2/20 0.52
MTOR P42345 2/20 0.52
RAB9A P51151 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3697783 1.00 CYP3A4 (0.61) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL3702133 0.88 CYP3A4 (0.76) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL7034831 0.87 CYP3A4 (0.49) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL2381627 0.86 CYP3A4 (0.65) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL2381626 0.86 CYP3A4 (0.65) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL8355729 0.86 CYP3A4 (0.79) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL8359519 0.86 CYP3A4 (0.79) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL8355732 0.86 CYP3A4 (0.79) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL3703324 0.84 CYP3A4 (0.46) CYP3A4CACNA1HCACNA1CCYP2D6MAPT
SCHEMBL7034587 0.79 CYP3A4 (0.59) CYP3A4CACNA1HCACNA1CCYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273009-B2 Tetrahydronaphthalene derivatives CONCERT PHARMACEUTICALS, INC. (US) 2016-03-01 US disclosed
US-20140155444-A1 TETRAHYDRONAPHTHALENE DERIVATIVES CONCERT PHARMACEUTICALS INC. (US) 2014-06-05 US disclosed
US-8575361-B2 Tetrahydronaphthalene derivatives CONCERT PHARMACEUTICALS INC. (US) 2013-11-05 US disclosed
US-20120122944-A1 TETRAHYDRONAPHTHALENE DERIVATIVES CONCERT PHARMACEUTICALS INC. (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155444-A1 TETRAHYDRONAPHTHALENE DERIVATIVES CACNA1H, CACNA1I, CACNA1G CYP3A4 1582/4885CACNA1H 1/4885CACNA1C 8/4885
US-20120122944-A1 TETRAHYDRONAPHTHALENE DERIVATIVES CACNA1H, CACNA1I, CACNA1G CYP3A4 1582/4885CACNA1H 1/4885CACNA1C 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.